Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 650x99px
Product › Details

6560 Ion Mobility Q-TOF LC/MS system (Agilent)

Products Next higher product group hybrid Quad-ToF (QTOF) mass spectrometer
Period Status 2014-06-17 sales existent
     

Agilent Technologies Inc.. (6/17/14). "Press Release: Agilent Technologies Thought Leader Award Supports Professor John A. McLean, Vanderbuilt University. Award Recognizes Pioneering Developments in Ion Mobility Q-TOF Technology". Santa Clara, CA.

Award Recognizes Pioneering Developments in Ion Mobility Q-TOF Technology for Lipidomic and Metabolomic Analysis


Agilent Technologies Inc. (NYSE: A) today announced that professor John A. McLean has received an Agilent Thought Leader Award in recognition of his contributions to ion mobility mass spectrometry (IM-MS) focused on advanced applications, including comprehensive biomolecular systems analysis and synthetic and chemical biology.

Dr. McLean is a Stevenson Professor of Chemistry at the Department of Chemistry at Vanderbilt University. He is co-director of the Automated Biosystems Core and deputy director of the Institute of Integrative Biosystems Research and Education.

The award will support Dr. McLean and his team at Vanderbilt in their pioneering metabolomics and lipidomics research through the advancement of ion mobility informatics and workflows.

"We are grateful to Agilent for this Thought Leader Award because it affirms our research efforts in untargeted broad-scale molecular analysis at the intersection of integrative biology and translational research," said Dr. McLean.

"We are pleased to recognize John McLean as an Agilent Thought Leader," said John C. Fjeldsted, Agilent's senior director of LC/MS Research and Development. "John and the Vanderbilt team demonstrate a unique combination of driving fundamental instrumental development and pioneering solutions to address tremendously complex real-time biological applications."

Dr. McLean and his team are using Agilent's 6560 Ion Mobility Q-TOF LC/MS, 1290 UHPLC and data analysis and visualization software.

For details about Dr. McLean's work, visit Agilent's 2014 ASMS Media Kit and select the presentation titled "Structural Mass Spectrometry for the Analysis of Complex Biological Samples: Ion Mobility-Mass Spectrometry for Broad-Scale Systems and Synthetic Biology."

The Agilent Thought Leader Award promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences, diagnostics and chemical analysis. Information about previous award recipients is available at Agilent's Thought Leader Program website.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at www.agilent.com.

On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.

# # #

Contact:

Susan Berg
+1 408 553 7093
susan_berg1@agilent.com

   
Record changed: 2016-03-19

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x112px

More documents for hybrid Quad-ToF (QTOF) mass spectrometer


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 650x65px




» top